11/18
08:07 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $18.00 price target on the stock.
Low
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $18.00 price target on the stock.
11/5
08:00 am
engn
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
Medium
Report
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
10/25
08:00 am
engn
enGene Announces $60 Million Private Placement Financing
Low
Report
enGene Announces $60 Million Private Placement Financing
10/22
04:05 pm
engn
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
10/21
08:45 am
engn
enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer
Medium
Report
enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer
10/3
07:21 am
engn
Insider Buys Additional US$57k In enGene Holdings Stock [Yahoo! Finance]
Low
Report
Insider Buys Additional US$57k In enGene Holdings Stock [Yahoo! Finance]
10/1
04:05 pm
engn
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9/26
06:30 am
engn
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
High
Report
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
9/24
09:14 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $30.00 price target on the stock.
Medium
Report
enGene Holdings Inc. (NASDAQ: ENGN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $30.00 price target on the stock.
9/11
12:19 pm
engn
enGene Holdings Inc. (NASDAQ: ENGN) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $40.00 price target on the stock.
Low
Report
enGene Holdings Inc. (NASDAQ: ENGN) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $40.00 price target on the stock.
9/10
04:38 pm
engn
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
Medium
Report
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
9/10
04:33 pm
engn
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update
Medium
Report
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update
8/28
04:05 pm
engn
enGene to Participate in Upcoming Investor Conferences
Low
Report
enGene to Participate in Upcoming Investor Conferences
8/28
08:06 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock.
Medium
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock.